Semaglutide Injections

Semaglutide is a GLP-1 receptor agonist used to regulate blood sugar, reduce appetite, and slow gastric emptying, aiding in weight management.

• The description claims clinical studies showed participants lost an average of 16.9% of their body weight over 68 weeks.
• The description claims Semaglutide positively influences cardiovascular health and insulin sensitivity.
• The description states that compounded Semaglutide is not FDA-approved and has not undergone the same testing as FDA-approved medications.